Pilot Clinical Study of CT1812 in Mild to Moderate Alzheimer's Disease Using EEG
Study sponsor: Cognition Therapeutics
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-04-26Actual
Enrollment · participants16Actual
Source updated2024-11-29Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.